• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨噬细胞衍生的外泌体促进糖尿病肾病中肾小球系膜细胞 NLRP3 炎性小体的激活和自噬缺陷。

Macrophage-derived exosomes promote activation of NLRP3 inflammasome and autophagy deficiency of mesangial cells in diabetic nephropathy.

机构信息

The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, PR China; Department of Pharmacy, Guangzhou Panyu Maternal and Child Health Hospital, Guangzhou, Guangdong, PR China.

The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, PR China.

出版信息

Life Sci. 2023 Oct 1;330:121991. doi: 10.1016/j.lfs.2023.121991. Epub 2023 Jul 29.

DOI:10.1016/j.lfs.2023.121991
PMID:37524161
Abstract

Dysfunction of mesangial cells plays a significant role in the glomerular lesions and is implicated in the pathophysiology of diabetic nephropathy (DN). Macrophages infiltration is the main pathological feature of DN, which can ultimately lead to renal inflammation. Recent studies suggest that the crosstalk between kidney resident cells and inflammatory cells influences the development of DN, and that controlling this crosstalk may help treat DN. Here, we found that DN mice appeared renal pathological damage, including dilation of mesangial matrix and significant infiltration of macrophages, accompanied by increased inflammatory response, NLRP3 inflammasome activation and autophagy deficiency. Additionally, mesangial cells internalized exosomes from high glucose (HG) treated macrophage, resulting the activation of inflammatory cytokines and NLRP3 inflammasome and deficiency of autophagy in vitro and in vivo. Moreover, C57BL/6 mice injected HG-stimulated macrophages-derived exosomes exhibited renal dysfunction and mesangial matrix expansion. Taken together, the present study demonstrated that mesangial cells responded to HG treated macrophage-derived exosomes by promoting the activation of NLRP3 inflammasome and autophagy deficiency, thereby participating in the development of DN.

摘要

系膜细胞功能障碍在肾小球病变中起重要作用,并与糖尿病肾病 (DN) 的病理生理学有关。巨噬细胞浸润是 DN 的主要病理特征,可最终导致肾脏炎症。最近的研究表明,肾脏固有细胞与炎症细胞之间的串扰影响 DN 的发展,控制这种串扰可能有助于治疗 DN。在这里,我们发现 DN 小鼠出现肾脏病理损伤,包括系膜基质扩张和巨噬细胞大量浸润,同时伴有炎症反应增强、NLRP3 炎性小体激活和自噬不足。此外,系膜细胞内化了高糖 (HG) 处理的巨噬细胞来源的外泌体,导致体外和体内炎症细胞因子和 NLRP3 炎性小体的激活以及自噬不足。此外,向 C57BL/6 小鼠注射 HG 刺激的巨噬细胞衍生的外泌体可导致肾功能障碍和系膜基质扩张。总之,本研究表明,系膜细胞通过促进 NLRP3 炎性小体的激活和自噬不足来响应 HG 处理的巨噬细胞衍生的外泌体,从而参与 DN 的发生发展。

相似文献

1
Macrophage-derived exosomes promote activation of NLRP3 inflammasome and autophagy deficiency of mesangial cells in diabetic nephropathy.巨噬细胞衍生的外泌体促进糖尿病肾病中肾小球系膜细胞 NLRP3 炎性小体的激活和自噬缺陷。
Life Sci. 2023 Oct 1;330:121991. doi: 10.1016/j.lfs.2023.121991. Epub 2023 Jul 29.
2
Interleukin-22 ameliorated renal injury and fibrosis in diabetic nephropathy through inhibition of NLRP3 inflammasome activation.白细胞介素-22通过抑制NLRP3炎性小体激活改善糖尿病肾病中的肾损伤和纤维化。
Cell Death Dis. 2017 Jul 20;8(7):e2937. doi: 10.1038/cddis.2017.292.
3
Optineurin inhibits NLRP3 inflammasome activation by enhancing mitophagy of renal tubular cells in diabetic nephropathy.视神经萎缩症相关蛋白通过增强糖尿病肾病肾小管细胞的线粒体自噬抑制 NLRP3 炎性小体的激活。
FASEB J. 2019 Mar;33(3):4571-4585. doi: 10.1096/fj.201801749RRR. Epub 2018 Dec 20.
4
NLRP3 inflammasome negatively regulates podocyte autophagy in diabetic nephropathy.NLRP3 炎性小体负向调节糖尿病肾病足细胞自噬。
Biochem Biophys Res Commun. 2020 Jan 15;521(3):791-798. doi: 10.1016/j.bbrc.2019.10.194. Epub 2019 Nov 6.
5
Protective effect of ginsenoside metabolite compound K against diabetic nephropathy by inhibiting NLRP3 inflammasome activation and NF-κB/p38 signaling pathway in high-fat diet/streptozotocin-induced diabetic mice.化合物 K 通过抑制 NLRP3 炎性小体激活和 NF-κB/p38 信号通路对高脂饮食/链脲佐菌素诱导的糖尿病小鼠糖尿病肾病的保护作用。
Int Immunopharmacol. 2018 Oct;63:227-238. doi: 10.1016/j.intimp.2018.07.027. Epub 2018 Aug 11.
6
Complanatoside A targeting NOX4 blocks renal fibrosis in diabetic mice by suppressing NLRP3 inflammasome activation and autophagy.靶向NOX4的Complanatoside A通过抑制NLRP3炎性小体激活和自噬来阻断糖尿病小鼠的肾纤维化。
Phytomedicine. 2022 Sep;104:154310. doi: 10.1016/j.phymed.2022.154310. Epub 2022 Jul 5.
7
Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy.NLRP3 炎性小体抑制可通过抑制脂滴蓄积改善糖尿病肾病足细胞损伤。
Metabolism. 2021 May;118:154748. doi: 10.1016/j.metabol.2021.154748. Epub 2021 Mar 4.
8
Sarsasapogenin alleviates diabetic nephropathy through suppression of chronic inflammation by down-regulating PAR-1: In vivo and in vitro study.薯蓣皂苷元通过下调 PAR-1 抑制慢性炎症减轻糖尿病肾病:体内和体外研究。
Phytomedicine. 2020 Nov;78:153314. doi: 10.1016/j.phymed.2020.153314. Epub 2020 Aug 26.
9
Novel biphenyl diester derivative AB-38b inhibits NLRP3 inflammasome through Nrf2 activation in diabetic nephropathy.新型联苯二酯衍生物 AB-38b 通过激活 Nrf2 抑制糖尿病肾病中的 NLRP3 炎性小体。
Cell Biol Toxicol. 2020 Jun;36(3):243-260. doi: 10.1007/s10565-019-09501-8. Epub 2019 Nov 25.
10
Targeting the NLRP3 Inflammasome in Diabetic Nephropathy.靶向 NLRP3 炎性小体治疗糖尿病肾病。
Curr Med Chem. 2021;28(42):8810-8824. doi: 10.2174/0929867328666210705153109.

引用本文的文献

1
Oxidative-Inflammatory Crosstalk and Multi-Target Natural Agents: Decoding Diabetic Vascular Complications.氧化-炎症相互作用与多靶点天然药物:解读糖尿病血管并发症
Curr Issues Mol Biol. 2025 Aug 4;47(8):614. doi: 10.3390/cimb47080614.
2
Mesangial Cells in Diabetic Kidney Disease: From Mechanisms to Therapeutic Implications.糖尿病肾病中的系膜细胞:从发病机制到治疗意义
Int J Biol Sci. 2025 Jul 24;21(11):4762-4781. doi: 10.7150/ijbs.114907. eCollection 2025.
3
Role of the NLRP3 inflammasome in diabetes and its complications (Review).
NLRP3炎性小体在糖尿病及其并发症中的作用(综述)
Mol Med Rep. 2025 Nov;32(5). doi: 10.3892/mmr.2025.13657. Epub 2025 Aug 24.
4
Exo-hydrogel therapy: a revolutionary approach to managing diabetic complications.外泌体水凝胶疗法:一种治疗糖尿病并发症的革命性方法。
J Nanobiotechnology. 2025 Aug 11;23(1):558. doi: 10.1186/s12951-025-03621-6.
5
NLRP3 Inflammasome-Mediated Pyroptosis in Diabetic Nephropathy: Pathogenic Mechanisms and Therapeutic Targets.NLRP3炎性小体介导的糖尿病肾病细胞焦亡:致病机制与治疗靶点
J Inflamm Res. 2025 Jun 25;18:8399-8418. doi: 10.2147/JIR.S524246. eCollection 2025.
6
Exosomes applications in kidney diseases.外泌体在肾脏疾病中的应用。
Mol Biol Rep. 2025 Jun 21;52(1):622. doi: 10.1007/s11033-025-10727-5.
7
Association between systemic inflammatory indicators on admission and mortality in critically ill patients with diabetic kidney disease based on the MIMIC-IV database: a cohort study.基于MIMIC-IV数据库的糖尿病肾病危重症患者入院时全身炎症指标与死亡率的关联:一项队列研究
Front Endocrinol (Lausanne). 2025 May 30;16:1503667. doi: 10.3389/fendo.2025.1503667. eCollection 2025.
8
Cross Talk Between Macrophages and Podocytes in Diabetic Nephropathy: Potential Mechanisms and Novel Therapeutics.糖尿病肾病中巨噬细胞与足细胞之间的相互作用:潜在机制与新型治疗方法
Mediators Inflamm. 2025 May 2;2025:8140479. doi: 10.1155/mi/8140479. eCollection 2025.
9
Extracellular Vesicles in Renal Inflammatory Diseases: Revealing Mechanisms of Extracellular Vesicle-Mediated Macrophage Regulation.肾脏炎症性疾病中的细胞外囊泡:揭示细胞外囊泡介导的巨噬细胞调节机制
Int J Mol Sci. 2025 Apr 12;26(8):3646. doi: 10.3390/ijms26083646.
10
Emerging roles of exosomes in the diagnosis and treatment of kidney diseases.外泌体在肾脏疾病诊断和治疗中的新作用。
Front Pharmacol. 2025 Apr 16;16:1525314. doi: 10.3389/fphar.2025.1525314. eCollection 2025.